These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 12624305)

  • 1. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies.
    Aktas B; Utz A; Hoenig-Liedl P; Walter U; Geiger J
    Stroke; 2003 Mar; 34(3):764-9. PubMed ID: 12624305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
    Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
    Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic phosphorylation of the focal adhesion-associated vasodilator-stimulated phosphoprotein in intact human platelets in response to cGMP- and cAMP-elevating platelet inhibitors.
    Nolte C; Eigenthaler M; Horstrup K; Hönig-Liedl P; Walter U
    Biochem Pharmacol; 1994 Oct; 48(8):1569-75. PubMed ID: 7980622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition.
    Horstrup K; Jablonka B; Hönig-Liedl P; Just M; Kochsiek K; Walter U
    Eur J Biochem; 1994 Oct; 225(1):21-7. PubMed ID: 7925440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of blood vessel vasodilator-stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide/cyclic GMP signaling.
    Ibarra-Alvarado C; Galle J; Melichar VO; Mameghani A; Schmidt HH
    Mol Pharmacol; 2002 Feb; 61(2):312-9. PubMed ID: 11809855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets.
    Sudo T; Ito H; Kimura Y
    Platelets; 2003 Sep; 14(6):381-90. PubMed ID: 14602552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mediation of platelet quiescence by NO-releasing polymers via cGMP-induced serine 239 phosphorylation of vasodilator-stimulated phosphoprotein.
    Major TC; Handa H; Brisbois EJ; Reynolds MM; Annich GM; Meyerhoff ME; Bartlett RH
    Biomaterials; 2013 Nov; 34(33):8086-96. PubMed ID: 23906514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells.
    Eigenthaler M; Nolte C; Halbrügge M; Walter U
    Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High glucose inhibits the aspirin-induced activation of the nitric oxide/cGMP/cGMP-dependent protein kinase pathway and does not affect the aspirin-induced inhibition of thromboxane synthesis in human platelets.
    Russo I; Viretto M; Barale C; Mattiello L; Doronzo G; Pagliarino A; Cavalot F; Trovati M; Anfossi G
    Diabetes; 2012 Nov; 61(11):2913-21. PubMed ID: 22837307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific inhibitory effects of the NO donor MAHMA/NONOate on human platelets.
    Kobsar A; Simonis S; Klinker E; Koessler A; Kuhn S; Boeck M; Koessler J
    Eur J Pharmacol; 2014 Jul; 735():169-76. PubMed ID: 24780647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway.
    Russo I; Del Mese P; Viretto M; Doronzo G; Mattiello L; Trovati M; Anfossi G
    Clin Biochem; 2008 Mar; 41(4-5):343-9. PubMed ID: 18022387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole.
    Liu Y; Oh SJ; Chang KH; Kim YG; Lee MY
    Biochem Pharmacol; 2013 Oct; 86(7):914-25. PubMed ID: 23876340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling.
    Mullershausen F; Friebe A; Feil R; Thompson WJ; Hofmann F; Koesling D
    J Cell Biol; 2003 Mar; 160(5):719-27. PubMed ID: 12604588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction.
    Oelze M; Mollnau H; Hoffmann N; Warnholtz A; Bodenschatz M; Smolenski A; Walter U; Skatchkov M; Meinertz T; Münzel T
    Circ Res; 2000 Nov; 87(11):999-1005. PubMed ID: 11090544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans.
    Li Z; Ajdic J; Eigenthaler M; Du X
    Blood; 2003 Jun; 101(11):4423-9. PubMed ID: 12576312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by sodium nitroprusside or PGE1 of tyrosine phosphorylation induced in platelets by thrombin or ADP.
    Oda A; Druker BJ; Smith M; Salzman EW
    Am J Physiol; 1992 Mar; 262(3 Pt 1):C701-7. PubMed ID: 1372480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation.
    Barale C; Buracco S; Cavalot F; Frascaroli C; Guerrasio A; Russo I
    Thromb Haemost; 2017 Jun; 117(6):1115-1128. PubMed ID: 28405672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase.
    Chang CC; Lu WJ; Chiang CW; Jayakumar T; Ong ET; Hsiao G; Fong TH; Chou DS; Sheu JR
    J Nutr Biochem; 2010 Dec; 21(12):1214-21. PubMed ID: 20015631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasodilator-stimulated protein phosphorylation in platelets is mediated by cAMP- and cGMP-dependent protein kinases.
    Waldmann R; Nieberding M; Walter U
    Eur J Biochem; 1987 Sep; 167(3):441-8. PubMed ID: 2820726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
    Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
    Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.